|
|
COmprehensive
|
|
Recognized as PharmaVoice Magazine’s 2012 “100 Most Inspiring Individuals in Life Sciences Industry” in the change agent category, Lahue’s prior roles involved inspiring value strategies and mobilizing cross-functional teams across an international matrix to achieve novel patient access pathways. Responsibilities included: designing evidence generation capabilities, leading R&D and marketing transformation initiatives, setting world-wide pricing strategies, advising M&A, and driving product value negotiations with payers, reimbursement authorities and HTA agencies. Betsy’s accountability at Fortune 500 healthcare companies included reporting to the CEO and Board of Directors as a member of the leadership team.
A PROVEN TRACK RECORD OF EXECUTING MARKET ACCESS
AND EVIDENCE STRATEGIES FOR INNOVATIVE PRODUCTS
PharmaceuticalAlkemi has experience: executing market development strategy to establish unmet need and foster rapid patient access through collaboration with U.S. government agencies, payers, patient group and clinical thought leaders, negotiating the use of patient report outcomes as a primary measure of efficacy with regulatory bodies in key markets, providing real-world evidence to FDA addressing safety outcomes, utilizing data-driven models to overturn coverage restrictions with regional payers, creating value communication tools for value committee analysis, establishing new treatment protocols, & gaining access across inpatient, outpatient and ambulatory settings of care.
|
Rare DiseaseAlkemi can help your organization with: negotiating early access to orphan therapies, creating novel funding models and facilitating engagement between academic medical centers, regulatory bodies, reimbursement authorities and health technology assessment groups in Europe, leading evidence generation and publication strategies, establishing differential clinical and economic outcomes in peer-review literature, presenting global pricing analyses to senior leadership to inform launch sequence, developing payer value dossiers, & providing value-based price points for M&A activity.
|
Medical DeviceAlkemi can support you through: transforming R&D process to embed value considerations in the earliest stages of innovation, executing pricing strategy and global real world outcomes studies to achieve unparalleled product adoption at launch, delivering clinical and economic value proposition to achieve new reimbursement, designing partnerships between multiple medical specialties, delivering new clinical guidelines and medical training programs to incorporate novel neurovascular procedures, & hiring and managing regional staff responsible for health policy, tender strategy, and customer value strategies in North America, Europe, Latin America and Asia Pacific.
|
